Longer life for artificial joints

Joel Linden ()
Additional contact information
Joel Linden: La Jolla Institute for Allergy and Immunology, La Jolla, California 92037, USA.

Nature, 2012, vol. 487, issue 7406, 179-180

Abstract: Drug candidates that are related to a common metabolite called adenosine inhibit inflammation and reduce bone destruction in artificial joints. The finding suggests a potential approach to increasing the durability of prosthetic implants.

Date: 2012
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/487179a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:487:y:2012:i:7406:d:10.1038_487179a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/487179a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().